FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296100672> ?p ?o ?g. }

• W4296100672 abstract "To describe the clinical characteristics and outcomes of adult macrophage activation syndrome (MAS) patients and to provide experience for the treatment.Adult patients with MAS admitted to Beijing Friendship Hospital from December 2014 to September 2021 were enrolled in this study. Clinical data of patients were collected and analyzed.A total of 118 adult MAS patients entered this study. MAS was the first manifestation in 43 (36.4%) patients, while 75 (63.6%) developed MAS after the diagnosis of autoimmune disease (AID) with a median diagnostic interval of 2 (0.5-359) months. Eighty-two patients were initially treated with glucocorticoid-based regimen; the overall response (OR) rate at the 2-week posttreatment was 37.8%. Forty-five patients switched to etoposide-based regimen, and the OR rate was 84.4%. Thirty-six patients were initially treated with etoposide-based regimen, and the OR rate at the 2-week posttreatment was 80.6%. Serum IL-18 (P = 0.021), IFN-γ (P = 0.013), IP-10 (P = 0.001), IL-10 (P = 0.041), IL-1RA (P < 0.001), and TNF-α (P = 0.020) levels of patients were significantly decreased in the remission phase than in the active phase. Levels of SDF-1α (P = 0.018) and IL-7 (P = 0.022) were higher in refractory patients, while the GRO-α level had a strong tendency toward statistical significance (P = 0.050). The probability of overall survival (OS) at 3, 6, and 36 months after HLH diagnosis were 89.8%, 89.0%, and 87.9%, retrospectively. The active MAS status at the 2-week post initial treatment [P = 0.009, HR = 15.281, 95% CI, (0.1.972, 118.430)] and baseline neutrophil count (Neu) <1.5 × 109/l [P = 0.017, HR = 3.678, 95% CI, (1.267, 10.672)] were negative prognostic factors.MAS typically occurs within 2 months after the onset of autoimmune disease in adults. SDF-1α, IL-7, and GRO-α could be used to predict refractory MAS. The etoposide-based regimen is effective and tolerable for adult MAS." @default.
• W4296100672 created "2022-09-17" @default.
• W4296100672 creator A5000681251 @default.
• W4296100672 creator A5007428061 @default.
• W4296100672 creator A5014171327 @default.
• W4296100672 creator A5043348959 @default.
• W4296100672 creator A5051221401 @default.
• W4296100672 creator A5057765179 @default.
• W4296100672 creator A5070070561 @default.
• W4296100672 creator A5072097629 @default.
• W4296100672 date "2022-09-15" @default.
• W4296100672 modified "2023-10-09" @default.
• W4296100672 title "Macrophage activation syndrome in adults: Characteristics, outcomes, and therapeutic effectiveness of etoposide-based regimen" @default.
• W4296100672 cites W1505537322 @default.
• W4296100672 cites W1585868534 @default.
• W4296100672 cites W161302449 @default.
• W4296100672 cites W1925777576 @default.
• W4296100672 cites W1978089430 @default.
• W4296100672 cites W2008299431 @default.
• W4296100672 cites W2026404803 @default.
• W4296100672 cites W2034732127 @default.
• W4296100672 cites W2043530968 @default.
• W4296100672 cites W2062404751 @default.
• W4296100672 cites W2063582591 @default.
• W4296100672 cites W2070086022 @default.
• W4296100672 cites W2086188037 @default.
• W4296100672 cites W2110137421 @default.
• W4296100672 cites W2120380892 @default.
• W4296100672 cites W2125518260 @default.
• W4296100672 cites W2148714420 @default.
• W4296100672 cites W2162251899 @default.
• W4296100672 cites W2163067702 @default.
• W4296100672 cites W2188441859 @default.
• W4296100672 cites W2188969807 @default.
• W4296100672 cites W2265918137 @default.
• W4296100672 cites W2304277276 @default.
• W4296100672 cites W2316755057 @default.
• W4296100672 cites W2444247510 @default.
• W4296100672 cites W2611521090 @default.
• W4296100672 cites W2618817653 @default.
• W4296100672 cites W2782063053 @default.
• W4296100672 cites W2790210283 @default.
• W4296100672 cites W2802274402 @default.
• W4296100672 cites W2912679257 @default.
• W4296100672 cites W3043485311 @default.
• W4296100672 cites W3044576993 @default.
• W4296100672 cites W3083453970 @default.
• W4296100672 cites W3094069172 @default.
• W4296100672 cites W3111397800 @default.
• W4296100672 cites W3128130986 @default.
• W4296100672 cites W3130908087 @default.
• W4296100672 cites W3144130743 @default.
• W4296100672 cites W4212867768 @default.
• W4296100672 cites W4220920091 @default.
• W4296100672 cites W4241263512 @default.
• W4296100672 doi "https://doi.org/10.3389/fimmu.2022.955523" @default.
• W4296100672 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36189240" @default.
• W4296100672 hasPublicationYear "2022" @default.
• W4296100672 type Work @default.
• W4296100672 citedByCount "3" @default.
• W4296100672 countsByYear W42961006722022 @default.
• W4296100672 countsByYear W42961006722023 @default.
• W4296100672 crossrefType "journal-article" @default.
• W4296100672 hasAuthorship W4296100672A5000681251 @default.
• W4296100672 hasAuthorship W4296100672A5007428061 @default.
• W4296100672 hasAuthorship W4296100672A5014171327 @default.
• W4296100672 hasAuthorship W4296100672A5043348959 @default.
• W4296100672 hasAuthorship W4296100672A5051221401 @default.
• W4296100672 hasAuthorship W4296100672A5057765179 @default.
• W4296100672 hasAuthorship W4296100672A5070070561 @default.
• W4296100672 hasAuthorship W4296100672A5072097629 @default.
• W4296100672 hasBestOaLocation W42961006721 @default.
• W4296100672 hasConcept C121332964 @default.
• W4296100672 hasConcept C126322002 @default.
• W4296100672 hasConcept C142424586 @default.
• W4296100672 hasConcept C2776694085 @default.
• W4296100672 hasConcept C2778119113 @default.
• W4296100672 hasConcept C2779134260 @default.
• W4296100672 hasConcept C2779613421 @default.
• W4296100672 hasConcept C2781413609 @default.
• W4296100672 hasConcept C71924100 @default.
• W4296100672 hasConcept C87355193 @default.
• W4296100672 hasConcept C90924648 @default.
• W4296100672 hasConceptScore W4296100672C121332964 @default.
• W4296100672 hasConceptScore W4296100672C126322002 @default.
• W4296100672 hasConceptScore W4296100672C142424586 @default.
• W4296100672 hasConceptScore W4296100672C2776694085 @default.
• W4296100672 hasConceptScore W4296100672C2778119113 @default.
• W4296100672 hasConceptScore W4296100672C2779134260 @default.
• W4296100672 hasConceptScore W4296100672C2779613421 @default.
• W4296100672 hasConceptScore W4296100672C2781413609 @default.
• W4296100672 hasConceptScore W4296100672C71924100 @default.
• W4296100672 hasConceptScore W4296100672C87355193 @default.
• W4296100672 hasConceptScore W4296100672C90924648 @default.
• W4296100672 hasFunder F4320321001 @default.
• W4296100672 hasLocation W42961006721 @default.
• W4296100672 hasLocation W42961006722 @default.
• W4296100672 hasLocation W42961006723 @default.
• W4296100672 hasOpenAccess W4296100672 @default.
• W4296100672 hasPrimaryLocation W42961006721 @default.

• next